StreetAlpha.app
Home › Stocks › ALLR

Allarity Therapeutics, Inc. (ALLR)

$0.79
▼ −9.25%
LAST CLOSE · NOV 20

Allarity Therapeutics develops cancer treatments, mainly stenoparib, and a companion diagnostic test to identify patients likely to benefit from them. It last closed at $0.79 on Nov 20, down 9.25% on the day. The next earnings report for ALLR is expected around Fri, Feb 12, 2027, after the close. For the quarter ended Sep 2026, ALLR reported EPS of -$0.39 on revenue of $5,000. Over its last 8 reports the stock moved an average of 4.8% the session after earnings.

AI Auto Pilots
Is ALLR in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ALLR.

Key Stats

Last 12 months
Results
Revenue
$350K
Net income
−$15.7M
−4493.7% margin
EPS (diluted)
−$0.98
−110.8% vs a year ago
Free cash flow
−$13.2M
−3785.4% margin
Valuation
Market cap
$12.6M
16.0M shares
P/E
–
No P/E while losing money
Price to sales
35.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$14.1M
At Sep 30
Shareholder equity
−$2.3M
Buybacks
$746K
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$1.3M−$1.3MFY2021FY2024: $0$0FY2024FY2025: $320K$320KFY2025

From ALLR's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 13). Last 12 months adds up the four latest quarters.

Next report
Feb 12
Estimated date · After the close
Reported EPS
-$0.39
Quarter ended Sep 2026
Year ago EPS
-$0.19
Same quarter last year
Revenue
$5,000
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $9.68Dec '24Mar 2025: -$0.25Mar '25Jun 2025: -$0.15Jun '25Sep 2025: -$0.19Sep '25Dec 2025: -$0.21Dec '25Mar 2026: -$0.17Mar '26Jun 2026: -$0.21Jun '26Sep 2026: -$0.39Sep '26Latest -$0.39
Revenue by quarter
Mar 2025: $0Mar '25Jun 2025: $0Jun '25Sep 2025: $0Sep '25Dec 2025: $320,000Dec '25Mar 2026: $25,000Mar '26Jun 2026: $0Jun '26Sep 2026: $5,000Sep '26Latest $5,000
How ALLR moved after its last 8 reports
Average move the session after a report ±4.8%
Aug 14, 2026After the close−2.2%
Apr 1, 2026Time not announced+3.7%
May 9, 2025After the close−2.9%
Mar 31, 2025After the close−2.9%
Nov 14, 2024Time not announced−2.8%
May 15, 2024Time not announced−13.8%
Mar 8, 2024Time not announced−0.7%
Nov 15, 2022After the close−10.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on ALLRStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on ALLR
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on ALLR

Technical Analysis

ALLR · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 18% below its 20 day and 24% below its 50 day average. It is 54% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 37), near oversold. The nearest support is the 52 week low at $0.77, and the nearest resistance the Pivot at $0.82.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 11.3%/day
Key levels
$1.8452 week high+132.9%
$1.21200 day average+53.2%
$1.13100 day average+43.0%
$0.9750 day average+22.8%
$0.9320 day average+17.7%
$0.92Swing high (Oct 16)+16.5%
$0.86Pivot R1+8.9%
$0.82Pivot+3.8%
$0.79Last close
$0.7752 week low−2.5%
$0.75Pivot S1−5.1%
Indicators
RSI (14)37.13Weak, oversold below 30Neutral
MACD-0.04Below its signal lineBearish
Stochastic10.6Near the bottom of its rangeOversold
ADX (14)15.2No clear trend
Williams %R-98.8Oversold below −80, overbought above −20Oversold
CCI (20)-154.5Oversold below −100, overbought above 100Oversold
Rate of change−18.6%Change over 10 sessionsBearish
ATR (14)$0.09Typical daily range, 11.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ALLR

What happened before

See how ALLR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow ALLR usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How ALLR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for ALLRHow many large options trades hit ALLR, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

ALLR Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ●10 buying vs 10 selling
  • ▼Held by funds -1.2 pts
  • ●Funds holding +0
  • ▼Superinvestors: 0 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding20200.0%
In funds' top 1000–
Held by funds6.8%8.0%−1.2 pts
New / increased5 / 58 / 3−9.1%
Reduced / sold out4 / 63 / 2+100.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ALLR institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ALLR is in one of them and how their past ALLR trades turned out.

ALLR in the AI portfolios
Loading…

ALLR News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ALLR in an article yet. Here's the latest on the wider market.

ALLR in the news

About Allarity Therapeutics

Allarity Therapeutics is a pharmaceutical company based in Boston, Massachusetts, that develops cancer treatments. Its main focus is stenoparib, a therapy being studied in ovarian cancer and small cell lung cancer. The company also develops its Drug Response Predictor platform, a companion diagnostic designed to identify which patients are most likely to benefit from a particular cancer drug.

Headquarters
Boston, MA